[Status of fractionated abrasion and vaginal endocervical cytology in diagnosis of endometrial cancer].
The predictive value of cervical cytology and uterine curettage in 150 endometrial carcinoma was investigated. Cytology proved negative in 56% of all carcinomas and in 42.2% of those in stage 2 or 3. Uterine curettage was found to have a false-negative rate of 6%, endocervical curettage of 5.3%. By contrast, we found a high false-positive rate of 70.8% for endocervical curettage. 13.2% of the 129 endometrial carcinoma stage 1 had a false-positive endocervical fraction. No residual disease was found in 4.7% of all 150 hysterectomy specimens. Negative cervical cytology seems to be a reasonably good predictor of actual cervical involvement, if a positive endocervical curettage is to be interpreted.
Schild
R
R
Frauenklinik der RWTH Aachen.
Kutta
T
T
D000230:Adenocarcinoma / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D000368:Aged; D004107:Dilatation and Curettage; D016889:Endometrial Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D004717:Endometrium / Q000473:pathology; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000601:surgery; D014626:Vaginal Smears